Life Quality Study for PFAPA Patient (PFAPA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02811705 |
Recruitment Status : Unknown
Verified June 2016 by Véronique Hentgen, Versailles Hospital.
Recruitment status was: Recruiting
First Posted : June 23, 2016
Last Update Posted : June 23, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
PFAPA Syndrome | Other: Quality of life |
Study Type : | Observational |
Estimated Enrollment : | 100 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Study Start Date : | July 2015 |
Estimated Primary Completion Date : | July 2017 |
Estimated Study Completion Date : | July 2017 |

Group/Cohort | Intervention/treatment |
---|---|
PFAPA group
Life quality for PFAPA patient report by themselves or parent
|
Other: Quality of life
Quality of life |
FMF group
Life quality for FMF patient report by themselves or parent
|
Other: Quality of life
Quality of life |
- Compare quality of life from patients with PFAPA and FMF, reported by parents and by patients themselves [ Time Frame: 1 day ]
- Evaluate the fatigue status of patients through questionnaire PedsQL TM 3.0 multidimensional scale tiredness [ Time Frame: 1 day ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 2 Years to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- PFAPA syndrome patients or FMF patients
Exclusion Criteria:
- Participation refusal

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02811705
Contact: Laure Morisset | lmorisset@ch-versailles.fr |
France | |
Centre hospitalier de Versailles | Recruiting |
Le Chesnay, France | |
Contact: Veronique Hentgen | |
CH de Bicètre | Recruiting |
Paris, France |
Responsible Party: | Véronique Hentgen, Dr, Versailles Hospital |
ClinicalTrials.gov Identifier: | NCT02811705 |
Other Study ID Numbers: |
P15/13_PFAPA |
First Posted: | June 23, 2016 Key Record Dates |
Last Update Posted: | June 23, 2016 |
Last Verified: | June 2016 |